OIS XIII Speakers 2023

Hannah H. Chang is a Managing Director at Platanus, a global evergreen investment fund. Dr. Chang leads the firm’s healthcare venture capital strategy, investing in…

Mark L. Baum is the founder, Chairman of the Board, and CEO of Harrow. For the 2014-2017 periods, Harrow (formerly Imprimis Pharmaceuticals) was named by…

Dr. Frank W. Bowden, III, is the founder of Bowden Eye & Associates, a successful integrated eye care practice which he established in Jacksonville, Florida…

Jonathan Liu is Senior Director of Business Development at Topcon Healthcare responsible for corporate venture capital investments. He previously served as Global Director of Product…

Since 2019, Josh Chiwata has been the Director of Venture Management and Global Business Development at Santen, Inc. Prior to this role, he served as…

Doug is an entrepreneurial life scientist-PhD immunologist with more than twenty years of professional experience spanning both major pharmaceutical and academic environments. His collective expertise…

Murielle joined Intuitive Ventures in 2023. She is a senior investor and brings a depth of experience across digital health, diagnostics, and biotech domains to…

Babak is a 30+ year veteran of the healthcare industry, serving in executive roles at leading corporations, such as Johnson & Johnson. He currently leads…

Robert N. Weinreb, M.D. is the Chair and Distinguished Professor of Ophthalmology at the University of California, San Diego as well as Director of the…

Todd Pinkney has more than 25 years of leadership experience in medical devices, biologics, and pharmaceuticals across all aspects of commercialization including sales, marketing, analytics,…